We can't find the internet
Attempting to reconnect
19205.1 PFLS-LS
Discovery & development of novel cancer immunotherapeutics
Zusammenfassung
Discovery & development of novel cancer immunotherapeutics
Weitere Texte
Abstract
Boosting tumor-directed immune responses by inhibiting tumor evasion mechanisms bears significant therapeutic promise. Although unprecedented clinical success has been achieved by blockade of immune checkpoint pathways, these therapies still have only partial efficacy. Our goal is to develop first-in-class neutralising monoclonal antibodies against a novel immune checkpoint regulator that we have identified, with the aim of strengthening antitumor immunity in cancer patients.
Beteiligte
Walter Reith
Kontaktperson
walter.reith@unige.ch
Université de Genève Walter Reith Rue Michel Servet 1 1211 Genève GE CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2016-08-31
- Enddatum
- 2018-02-28
- Bewilligte Gesamtkosten
- CHF 332545.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T490 Biotechnology 100.0%